| abstract |
Pharmaceutical prepns. for corticoid therapy, in which the immunosuppressive action of the corticoid is neutralised or reduced without loss of anti-inflammatory activity, contain sulphate-, phosphate- or carboxylate-contg. oligomers or polymers, pref. in combination with corticoids, together with inert carrier materials. Prefd. prepns. contain 0.01-250 mg. of the oligomer or polymer and 0.01-250 mg. of the corticoid per dosage unit, the wt. ratio of polymer to corticoid pref. being 0.01-50:1. |